Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Georgian Med News ; (274): 92-97, 2018 Jan.
Artigo em Russo | MEDLINE | ID: mdl-29461234

RESUMO

Aim of study‒ estimate the influence of the metformin therapy on the sCD40-ligand and sVE-cadherinlevels among patients with acute myocardial infarction and concomitant type 2 diabetes mellitus. The study included44patients with AMI and type 2 diabetes whichweredividedintotwo groupsdependingonthe glucose lowering drugs they have been taken: I group ‒ 21patients who have been taken metformin; II group ‒ 23patients, who have been taken short-acting insulin. Accordingtotheobtainedresults using of metformin as a glucose lowering drug in comparison with patients who have been taken short-acting insulin causes faster decreasing of the sCD40L level (-29,3% and -24,4% accordingly; р<0,05). Whereas there was no significant differencesin the dynamics of sVE-cadherinlevels (-22,4% and -19,2% accordingly; р>0,05). Positive influence of them et form in on thes CD40-ligand level probably is caused by the inhibition of the Akt-kinase phosphorylation responsible for the activation of the nuclear factor kappa-b which controls expression of the immune response genes, particulary CD40. It leads to the inhibition of the thrombocytes activation and differentiation of the monocytes to the macrophages able to product proatherogenic factors. It was established that metformin therapy among patients with acute myocardial infarction and diabetes mellitus type 2 leads to the faster decreasing of sCD40-ligand in comparison with insulin therapy, which can contribute to the improvemenet of the prognosis in this cohort.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Endotélio Vascular/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Hipoglicemiantes/uso terapêutico , Insulina de Ação Curta/uso terapêutico , Metformina/uso terapêutico , Infarto do Miocárdio/tratamento farmacológico , Antígenos CD/sangue , Antígenos CD/genética , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Plaquetas/efeitos dos fármacos , Plaquetas/metabolismo , Plaquetas/patologia , Ligante de CD40/sangue , Ligante de CD40/genética , Caderinas/sangue , Caderinas/genética , Diferenciação Celular/efeitos dos fármacos , Estudos de Coortes , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/patologia , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Feminino , Hemoglobinas Glicadas/genética , Hemoglobinas Glicadas/metabolismo , Humanos , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Macrófagos/patologia , Masculino , Pessoa de Meia-Idade , Monócitos/efeitos dos fármacos , Monócitos/metabolismo , Monócitos/patologia , Infarto do Miocárdio/sangue , Infarto do Miocárdio/genética , Infarto do Miocárdio/patologia , NF-kappa B , Fosforilação/efeitos dos fármacos , Ativação Plaquetária/efeitos dos fármacos , Prognóstico , Proteínas Proto-Oncogênicas c-akt/genética , Proteínas Proto-Oncogênicas c-akt/metabolismo , Transdução de Sinais
2.
Biochemistry (Mosc) ; 81(9): 986-98, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27682171

RESUMO

Dioxygenases induced during benzoate degradation by the actinobacterium Rhodococcus wratislaviensis G10 strain degrading haloaromatic compounds were studied. Rhodococcus wratislaviensis G10 completely degraded 2 g/liter benzoate during 30 h and 10 g/liter during 200 h. Washed cells grown on benzoate retained respiration activity for more than 90 days, and a high activity of benzoate dioxygenase was recorded for 10 days. Compared to the enzyme activities with benzoate, the activity of benzoate dioxygenases was 10-30% with 13 of 35 substituted benzoate analogs. Two dioxygenases capable of cleaving the aromatic ring were isolated and characterized: protocatechuate 3,4-dioxygenase and catechol 1,2-dioxygenase. Catechol inhibited the activity of protocatechuate 3,4-dioxygenase. Protocatechuate did not affect the activity of catechol 1,2-dioxygenase. A high degree of identity was shown by MALDI-TOF mass spectrometry for protein peaks of the R. wratislaviensis G10 and Rhodococcus opacus 1CP cells grown on benzoate or LB. DNA from the R. wratislaviensis G10 strain was specifically amplified using specific primers to variable regions of genes coding α- and ß-subunits of protocatechuate 3,4-dioxygenase and to two genes of the R. opacus 1CP coding catechol 1,2-dioxygenase. The products were 99% identical with the corresponding regions of the R. opacus 1CP genes. This high identity (99%) between the genes coding degradation of aromatic compounds in the R. wratislaviensis G10 and R. opacus 1CP strains isolated from sites of remote location (1400 km) and at different time (20-year difference) indicates a common origin of biodegradation genes of these strains and a wide distribution of these genes among rhodococci.


Assuntos
Proteínas de Bactérias , Dioxigenases , Genes Bacterianos/fisiologia , Bifenilos Policlorados/metabolismo , Rhodococcus , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Dioxigenases/genética , Dioxigenases/metabolismo , Rhodococcus/enzimologia , Rhodococcus/genética
3.
Arch Razi Inst ; 75(2): 257-265, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32621457

RESUMO

This study investigated a person with an AB0 discrepancy. Her blood group initially typed at the birth as AB Rh+ (positive); however, it was B Rh+ (positive) or Rh- (negative) when she was in her teens. At room temperature, her erythrocytes were agglutinated by anti-B, and the agglutination was significantly weaker at 37 &ordm;C. As a result, her erythrocytes did not absorb anti-B but anti-A. Furthermore, her erythrocytes were agglutinated by anti-A at 37 &ordm;C with signs of hemolysis in the presence of complement. The unwashed erythrocytes were also agglutinated in an antiglobulin test by polyclonal anti-A at 37 &ordm;C and by heated polyclonal anti-A and anti-A MAB 2-8 at room temperature. Moreover, her serum agglutinated A erythrocytes at room temperature with less activity at 37 &ordm;C; however, it agglutinated B erythrocytes at 37 &ordm;C. The ability of the erythrocytes of this person to absorb anti-A came along with the agglutination of her erythrocytes at 37 &ordm;C by polyclonal serum and decreased activity of the serum to agglutinate A erythrocytes at 37 &ordm;C, compared to room temperature. The absence of anti-B absorbance by the person&rsquo;s erythrocytes was accompanied by the presence of anti-B in the serum, which was active at 37 &ordm;C. The incubation of the person&rsquo;s serum with 0 erythrocytes induced the ability of erythrocytes to absorb anti-A and to be hemolyzed by anti-A in the presence of complement in accordance with the person&rsquo;s characteristics of erythrocytes. The reaction of absorption and agglutination at room temperature and 37 &ordm;C by heated serum with the use of complement may help to reveal both weak A and B antigens and anti-A and anti-B antibodies while AB0 blood typing.


Assuntos
Eritrócitos/imunologia , Sistema do Grupo Sanguíneo Rh-Hr/imunologia , Aglutinação/imunologia , Tipagem e Reações Cruzadas Sanguíneas , Proteínas do Sistema Complemento/imunologia , Teste de Coombs , Feminino , Humanos
4.
Anesteziol Reanimatol ; (3): 8-10, 2000.
Artigo em Russo | MEDLINE | ID: mdl-10900710

RESUMO

Auditory evoked potentials (AEP) were recorded and analyzed in 12 children during general halothane and ketamine anesthesia. Ketamine suppressed the amplitude of primary negative component and eliminated secondary AEP components with latencies more than 60 ms, including N-200 and P-300 waves. By contrast, halothane did not affect primary components with less than 95 ms latencies and suppressed the latest components. Hence, ketamine suppresses the nonspecific afferent pathways and the brain structures responsible for memory and emotional functions, while halothane does not affect the afferent pulsation and partially suppresses emotional and mnemonic functions.


Assuntos
Anestesia Geral/métodos , Potenciais Evocados Auditivos/efeitos dos fármacos , Estimulação Acústica/métodos , Adjuvantes Anestésicos , Adolescente , Anestésicos Dissociativos , Anestésicos Inalatórios , Anestésicos Intravenosos , Atropina , Criança , Diazepam , Potenciais Evocados Auditivos/fisiologia , Halotano , Humanos , Ketamina , Tempo de Reação/efeitos dos fármacos , Tempo de Reação/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA